United Therapeutics Corp (NASDAQ:UTHR)
| 208.65 BATS BZX Real-Time Price As of 12:46pm ET |  +3.40 / +1.66%Today’s Change | 201.65 Today|||52-Week Range 283.09 | -24.97% Year-to-Date |
Latest UTHR News | Press Releases
No recent news for United Therapeutics Corp.
Today’s Trading
| Previous close | 205.25 |
| Today’s open | 207.01 |
| Day’s range | 206.98 - 209.14 |
| Volume | 8,033 |
| Average volume (3 months) | 504,859 |
| Market cap | $9.7B |
Data as of 12:46pm ET, 05/31/2023
Growth & Valuation
| Earnings growth (last year) | +50.84% |
| Earnings growth (this year) | +25.14% |
| Earnings growth (next 5 years) | -7.08% |
| Revenue growth (last year) | +14.88% |
| P/E ratio | 14.1 |
| Price/Sales | 6.97 |
| Price/Book | 2.02 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| RGENRepligen Corp | -5.26 | -3.03% |
| APLSApellis Pharmaceutic... | -0.20 | -0.23% |
| RDYDr Reddy's Laborator... | +0.32 | +0.59% |
| ---- |
Data as of 12:46pm ET, 05/31/2023
Financials
| Next reporting date | August 2, 2023 |
| EPS forecast (this quarter) | $4.58 |
| Annual revenue (last year) | $1.9B |
| Annual profit (last year) | $727.3M |
| Net profit margin | 37.56% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Silver Spring, Maryland |
Forecasts
